Stockreport

Reneo Pharmaceuticals Reports Second Quarter 2024 Financial Results [Yahoo! Finance]

Reneo Pharmaceuticals, Inc.  (RPHM) 
PDF development and commercialization of therapies for patients with rare genetic mitochondrial diseases, today reported financial results for the second quarter ended June [Read more]